Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
With all of the 100s the m&m (market manipulators) walk the price down every time. They don't want the price over .03.
'News' will break their hold. There is very little selling, but between themselves.
Smokey,
Is this a triple bottom? If so, it is a bullish sign if it breaks above .028. What are your thoughts?
The Market Makers totally control the price of this stock. Look at the number of times throughout the day. The size 100 pops up.
The last at 15:40 for .0199. As I understand 100 means, 'I need shares'. Immediately the price dropped to .018. Throughout the day that has been the case. Who buys 100 shares...no one! I believe Market Makers signal each other. When will it ever quit??
UBQU has been adequately defended. I need to say nothing else.
Almost Retired...what has changed in 8 days? I quote 'almost retired' on 1/31/2016:
This is not a P & D.
Chart looks incredible and trading action has been consistent for weeks now.
Is this P&D or not???
AMFIL is on the move, and EAPH is to be 49% owner of GROzone.
Further to the launch of the GROzone sales initiative, Amfil Technologies is in discussions with a company that produces a revolutionary 'rotary' hydroponic growing system, which is poised to be the future of the production and manufacturing side of the industry. The 'rotary' system requires only a third of the floor space required by traditional hydroponic systems. This system is also stackable, which makes it possible for facilities to exponentially increase the volume of their production yields. Amfil is in discussions to create a customized GROzone system that would be sold as an add-on to the existing systems this company creates and sells. We hope to announce the closing of this deal in January 2017.
You are not correct. There are some 'free lunches'...if a couple makes under $75,000 adjusted gross (figure in all of your deductibles). The following was recently posted:
https://www.fool.com/retirement/2016/12/16/capital-gains-tax-rate-for-2017.aspx
If you hold a stock for over one year and your total adjusted income is less than $75,000 your tax is 0
It may pay you to hold a stock for over one year.
I came across Common Sense Ltd while researching for EAPH,. Their Common Sense Ltd was of Israel. Common Sense Holding may be a different company.
Common Sense is a company located in Israel.
Share count and more...read the 8 page report and much will be made clear. According to the report there are 185 million shares outstanding. It also gives the shares sold to pay down the debt:
http://www.otcmarkets.com/financialReportViewer?symbol=UBQU&id=165535
How did CSOC work for you??
Thanks!
I was concerned like everyone else, so I asked, and they replied.
Any investor could have done the same thing. If you don't ask,
all you can go on is what is presented on Investorshub or social media or wait, and wait and make the wrong decision or your investment.
I'm sure that all of the information I was getting here was accurate and looking our for my best interest. :)
Go to the source and see what they say. Anyone can ask.
The message given in private to an investor, share holder was not intended for public consumption. I couldn't help but share the good news that I received from the company. The company isn't at fault...I am. Sorry, if this causes a run up in the pps.
I also was concerned, so I wrote today.
I got this reply:
Thank you for contacting us and being such a loyal supporter. As a company we want our shareholders to know that we would never do anything to harm our company. product line, customers or shareholders, and that our intentions are to continue to grow a very healthy company, quarter by quarter.
I can tell you that our management team is on track and understands what you are saying as well. We are off to a great start in 2017 and the company looks forward to showing our shareholders our quarterly growth as well as all the great news and updates on the company.
In addition, expect at least two press releases per week starting next week. Have a wonderful evening and thanks again for being with us.
James
Support
-HempLife Today™
Is CBD from hemp legal?
The FDA of the United States considers hemp oil (and it's derivative CBD) to be a dietary supplement (not a medication), since they are made from industrial hemp plants. If you live in the US, this means you don't need a prescription and can legally purchase and consume Cannabidiol in any state.
Is CBD legal??
The FDA of the United States considers hemp oil (and it's derivative CBD) to be a dietary supplement (not a medication), since they are made from industrial hemp plants. If you live in the US, this means you don't need a prescription and can legally purchase and consume Cannabidiol in any state.
There are a couple that are making money:
UBQU and CVSI
IN doing my DD on Max Goldfarb I found the information on Inside Trader. I copied and pasted the information hoping someone on this site could provide some insight into what is taking place. 213 billion seems impossible, but that is what was reported.
Something is up!
[iMax Goldfarb Buys $213,615,855,000 Worth of $NGBL NOTIS GLOBAL INC COM USD0.0001 – #Form4 #InsiderTrading
On 11/08/16, Max Goldfarb, reported a net BUY trade of NGBL with a net transaction amount of $213,615,855,000. Net non-zero shares traded: 72310000. See below for more information on NOTIS GLOBAL INC COM USD0.0001 with symbol NGBL traded on the PNK. Original SEC Filing Period of Report: 2016-06-14
]
Share Countaccording to OTC Market:
As of August 24, 2016 Outstanding: 78,708,000 Float: 46,063,300
If that is correct, this stock will fly
Old...Old...Old News.
It works like this:
Many bought MDBX with less than 75 million shares. That's why the stock was purchased. The price never went below .05. Enter NGBL who issues billions of shares. The management and 'investors' will get paid plenty. Hundreds of millions of shares will be traded daily. Then there will be a BIG reverse split. Everyone is wiped out. The game starts all over again. Whatever happened to the hemp? Whatever happened to the purchase orders? It matters little. We will have so few shares that even if the company survives, the little share holder will get nothing.
Are folium biosciences and whole hemp the same organization?
You may be right...is all of this a lie???
Notis Global Announces Progress in Farming Operations
? Download as PDF
May 03, 2016
LOS ANGELES – (PR NEWSWIRE) – May 3, 2016 – Notis Global, Inc. (OTCQB: NGBL), a pioneer in the worldwide hemp and CBD oil industry, today issued a press release regarding progress on its Farm in Colorado.
2016 has been a pivotal year for Notis Global. Through Notis Global’s subsidiary EWSD I, LLC (“EWSD”), and its partner Folium Biosciences, one of the nation’s leading growers and processors of hemp products, based in Colorado Springs, Colorado, the company has made significant progress towards creating its first crop of the highest quality hemp for hemp oil production.
Throughout the winter and spring the managers and the employees of “the Farm” have constructed new or rehabilitated the existing farmhouse office and greenhouse structures on our land in Pueblo Colorado including grading the land and erecting security fences along with upgrading wells and piping for water. State of the art temperature, circulation and humidity controls along with appropriate drainage have all been installed and are operational in 36,000 square feet of greenhouses according to Jeff Goh President and CEO. See a recently updated video
#EAPH or Easton Looks Forward To Its Next Few Upcoming Press Releases And The Very Positive Developments In The Coming Few Short Days.
I'm not an expert. I just passed along the information that was given to me from AMFE.
I contacted AMFE today:
Good afternoon.....,
Thank you for reaching out to Amfil Technologies Inc. In response to your questions, Easton Pharmaceuticals made a direct investment into Amfil in I believe it was July of 2014 and were issued AMFE restricted common stock for their investment. Too my knowledge they are still a current shareholder in the company, yes.
Roger Mortimer
647.880.5887
Sent from my iPhone
> On Apr 5, 2016, at 1:44 PM, wrote:
>
> Does Amfil have any connection with Easton Pharmaceutical at this time?
> I am invested with EAPH and I have seen many supposed deals fall through.
> Is the relationship with AMFIL still active?
> Is EAPH legit?
> Thank you in advance.
I spoke with EAPH:
I spoke with Frank from EAPH. He called me after an inquiry that I had made by way of email through the company website. He said at the most there are 656 million o/s shares which is not near the 2.6 billion reported. They retired 200 million after the CA deal. He admitted they have made some big mistakes, but believes they are moving in the right direction. An update should be coming tomorrow or wed. The Mexican deal will be a game changer. They wait for approval from the government. Yes, EAPH does exist.
mjk...Thanks...
Massive Dilution is never good.
Are you sure about your numbers?
Shares Outstanding Analysis
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.
Easton Pharmaceuticals Shares Outstanding=Public Shares -Repurchased = 359.71 M
Cannabis Science Negotiates a Total 360,000 Sq. Ft. Licensed Cannabinoid Grow and Formulation Processing in Nevada, Including Facilities for Educational and Medical Clinic and Laboratory for Drug Development Programs Targeting Multiple Critical Ailments
Last update: 24/03/2016 12:08:33 pm
Cannabis Science Negotiates a Total 360,000 Sq. Ft. Licensed Cannabinoid Grow and Formulation Processing in Nevada, Including Facilities for Educational and Medical Clinic and Laboratory for Drug Development Programs Targeting Multiple Critical Ailments
COLORADO SPRINGS, CO--(Marketwired - Mar 24, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced the Company has negotiated a major new drug development and facilities deal in the State of Nevada. The premises include an approximately 360,000 sq. ft. licensed cannabinoid grow and a separate formulation processing operation in Nevada. The transaction includes access to a separate educational and research facility for its drug development programs targeting critical ailment research initiatives.
All parties involved are motivated and excited to get this landmark deal underway. It gives the Company and its investor partners access to over 360,000 sq. ft. of fully-licensed land for cannabis grow operations and full access to an educational, laboratory, and medical clinic location for formulation processing and further critical ailment research.
"The goal is to bring our cannabinoid formulations across the country and internationally 'much faster' and more efficiently, and, in addition, to improve the Company's output capacity from a manufacturing standpoint. Sometimes opportunity just falls in your lap when you persevere in 'doing the right thing.' So now we move forward with this massive deal, which covers a large amount of land. We at Cannabis Science are so excited to see our widespread rollout strategy starting to come to fruition. This Nevada opportunity was a complete surprise as we were more focused on targeting California expansions; however, of course when new and fortuitous circumstances present themselves, you must be fluid, open and respond accordingly. This is what we did. The added capacity this development deal and others like it provides should allow us to rapidly move into a much larger development and production capacity, to continue the advancement of our drug development programs while we provide our important formulations to patients in need sooner and in greater geographic areas," stated Cannabis Science President & CEO, Co-Founder Raymond C. Dabney.
This added capacity will allow the Company to further its drug development programs more quickly. The Company has targeted current success with a few critical ailments including Cancer, PTSD, HIV/AIDS, Autism, and Neurological disorders, utilizing and monitoring different cannabinoid formulations and delivery modules. The Company will have a much wider base to work from by expanding into the State of Nevada, drawing another very large targeted medical consumer base.
"We have a few more landmark growth agreements underway, such as our California initiatives that are advancing nicely. The Company has more watershed operational changes to announce upon completion. We have a few more pleasant surprises to compound our growth and solidify our position in this outstanding cannabis-based pharmaceutical industry growth curve. We understand our position and we know what needs to get done. We are excited, we are motivated, and we are on the move, in the right direction. We look forward to keeping everyone up to date with all our progress. Again we wish to thank our shareholders for their continued support along this amazing path," concluded Mr. Dabney.
What Might Have Been
CS Mining took over CPRK...look at them today:
Cs Mining LLC
A privately held company in Milford, UT. Is this your business? Claim This Profile
More Details for Cs Mining LLC
Categorized under Metal Mining Services. Our records show it was established in 2011 and incorporated in Utah. Current estimates show this company has an annual revenue of 22,300,000 and employs a staff of approximately 150.
Spin Off:
Date Event Type Eff/Ex Date Symbol Issue Name Market
01/29/2016 10:28:31 Spin-Off FITX Creative Edge Nutrition, Inc. Common Stock Other OTC
Comments
Shareholders will receive 1 share of CEN Biotech, Inc. for every 700 shares held. Will not be quoted Ex.
Details
Previous Value Current Value
Symbol FITX FITX
Issue Name Creative Edge Nutrition, Inc. Common Stock Creative Edge Nutrition, Inc. Common Stock
Class
Financial Status Indicator
Market Category Other OTC Other OTC
Current Value
Daily List Date 01/29/2016 10:28:31
Event Type Spin-Off
Daily List Event Code DA
Effective/Ex Date
Subject to Corporate Action
Offering Type No Restrictions
Forward Split Ratio
Reverse Split Ratio
Dividend Type Spin-Off
Percentage 0
Cash Amount 0
Declaration Date
Record Date 11/30/2015 00:00:00
Payment Date 02/29/2016 00:00:00
Payment Method MOD
Qualified Dividend Code
Daily List Comment Shareholders will receive 1 share of CEN Biotech, Inc. for every 700 shares held. Will not be quoted Ex.
My TD Ameritrade says, 'Removal of worthless stock' with my CPRKQ # and there is no new stocks that replaced the old.
mj could be a $35 billion business:
Marijuana could be a $35 billion market by 2020
By Kathleen Burke
Published: July 15, 2015 1:36 p.m. ET
Be patient, our time will come.
mj could be a $35 billion business:
Marijuana could be a $35 billion market by 2020
By Kathleen Burke
Published: July 15, 2015 1:36 p.m. ET
Nunzio Valerie Jr seems qualified:
Executive Profile
Nunzio J. Valerie Jr.
Chief Executive Officer and Director, SEAS Industries Inc.
Age Total Calculated Compensation This person is connected to 1 Board Members in 1 different organizations across 1 different industries.
See Board Relationships
52 --
Background
Mr. Nunzio J. Valerie Jr. serves as Chief Executive Officer at Seas Industries Inc. Mr. Valerie served as Chief Executive Officer of Viewcom Corp (a\k\a 2224942 Ontario Inc.). Mr. Valerie has been working as a Sales and Marketing Consultant since 2005. He served as Sales Manager of Holiday Health Fitness Centers from 1983 to 1985; Licensed Securities Broker from 1985 to 1997; Held Principal's License and managed Broker Dealers in Dallas, TX and Scottsdale, Arizona from...